Matinas Biopharma Holdings EPS - Earnings per Share 2012-2019 | MTNB

Matinas Biopharma Holdings eps - earnings per share from 2012 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Matinas Biopharma Holdings Annual EPS
2018 $-0.15
2017 $-0.36
2016 $-0.21
2015 $-0.18
2014 $-0.32
2013 $-0.20
2012 $-0.01
2011 $0.00
Matinas Biopharma Holdings Quarterly EPS
Q2 2019 $-0.03
Q1 2019 $-0.04
Q4 2018 $-0.03
Q3 2018 $-0.03
Q2 2018 $-0.04
Q1 2018 $-0.05
Q4 2017 $-0.03
Q3 2017 $-0.04
Q2 2017 $-0.04
Q1 2017 $-0.25
Q4 2016 $-0.03
Q3 2016 $-0.11
Q2 2016 $-0.03
Q1 2016 $-0.04
Q4 2015 $-0.03
Q3 2015 $-0.04
Q2 2015 $-0.04
Q1 2015 $-0.07
Q4 2014 $-0.09
Q3 2014 $-0.08
Q2 2014 $-0.08
Q1 2014 $-0.07
Q4 2013 $-0.06
Q3 2013 $-0.10
Q2 2013 $-0.03
Q1 2013 $-0.01
Q4 2012 $0.00
Q3 2012 $0.00
Q4 2011 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.111B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.352B 37.78
Takeda Pharmaceutical (TAK) Japan $53.895B 8.43
Astellas Pharma (ALPMY) Japan $29.205B 13.91
Merck (MKGAF) Germany $14.895B 20.33
Eisai (ESALY) Japan $14.570B 22.30
Grifols, S.A (GRFS) Spain $13.992B 17.85
UCB SA (UCBJF) Belgium $13.839B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.815B 19.01
Neurocrine Biosciences (NBIX) United States $8.272B 0.00
IPSEN SA ADR (IPSEY) France $7.776B 0.00
Sage Therapeutics (SAGE) United States $7.260B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Catalent (CTLT) United States $7.112B 28.11
Jazz Pharmaceuticals (JAZZ) Ireland $6.719B 8.84
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.216B 18.75
United Therapeutics (UTHR) United States $3.591B 0.00
FibroGen (FGEN) United States $3.241B 81.07
Evotec AG (EVTCY) Germany $3.183B 43.58
Arrowhead Pharmaceuticals (ARWR) United States $3.086B 70.76
Nektar Therapeutics (NKTR) United States $2.995B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.932B 10.51
PTC Therapeutics (PTCT) United States $2.172B 0.00
Tilray (TLRY) Canada $2.047B 0.00
Xencor (XNCR) United States $1.959B 42.71
Portola Pharmaceuticals (PTLA) United States $1.840B 0.00
Zogenix (ZGNX) United States $1.816B 0.00
Corcept Therapeutics (CORT) United States $1.603B 22.03
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.569B 57.11
USANA Health Sciences (USNA) United States $1.522B 15.27
Heron Therapeutics (HRTX) United States $1.428B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.379B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.162B 19.17
Radius Health (RDUS) United States $1.131B 0.00
ArQule (ARQL) United States $1.032B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
TherapeuticsMD (TXMD) United States $0.928B 0.00
Aerie Pharmaceuticals (AERI) United States $0.926B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.847B 0.00
Endo (ENDP) Ireland $0.839B 1.48
Dova Pharmaceuticals (DOVA) United States $0.818B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.814B 3.63
Organogenesis Holdings (ORGO) United States $0.716B 0.00
Concordia (CXRXF) Canada $0.633B 0.00
Karyopharm Therapeutics (KPTI) United States $0.632B 0.00
Akebia Therapeutics (AKBA) United States $0.512B 0.00
Flexion Therapeutics (FLXN) United States $0.509B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.497B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.463B 0.00
Lannett Co Inc (LCI) United States $0.447B 4.71
Siga Technologies (SIGA) United States $0.447B 1.04
ChemoCentryx (CCXI) United States $0.441B 0.00
Indivior (INVVY) United States $0.437B 1.58
Translate Bio (TBIO) United States $0.414B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.399B 0.00
Collegium Pharmaceutical (COLL) United States $0.395B 0.00
Innate Pharma SA (IPHYF) France $0.392B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.387B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.368B 16.75
Harpoon Therapeutics (HARP) United States $0.340B 0.00
ImmunoGen (IMGN) United States $0.337B 0.00
DURECT (DRRX) United States $0.326B 0.00
Dermira (DERM) United States $0.310B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.301B 0.00
Ardelyx (ARDX) United States $0.292B 0.00
OptiNose (OPTN) United States $0.283B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.270B 0.00
Molecular Templates (MTEM) United States $0.253B 0.00
Recro Pharma (REPH) United States $0.248B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.228B 0.00
Xeris Pharmaceuticals (XERS) United States $0.212B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.208B 0.00
GlycoMimetics (GLYC) United States $0.198B 0.00
KalVista Pharmaceuticals (KALV) United States $0.196B 0.00
CV Sciences (CVSI) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.178B 29.77
AcelRx Pharmaceuticals (ACRX) United States $0.174B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Calithera Biosciences (CALA) United States $0.140B 0.00
Concert Pharmaceuticals (CNCE) United States $0.140B 0.00
Ocular Therapeutix (OCUL) United States $0.139B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.135B 0.00
IMV INC (IMV) Canada $0.132B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
CannTrust Holdings (CTST) Canada $0.130B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.128B 0.00
Redhill Biopharma (RDHL) Israel $0.126B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Jounce Therapeutics (JNCE) United States $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 32.94
MediWound (MDWD) Israel $0.081B 0.00
Aquestive Therapeutics (AQST) United States $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.080B 0.00
Majesco Entertainment (PTE) United States $0.079B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.078B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Lipocine (LPCN) United States $0.069B 0.00
Otonomy (OTIC) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Genocea Biosciences (GNCA) United States $0.069B 0.00
RENEURON GP (RNUGF) United Kingdom $0.065B 0.00
Novan (NOVN) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.062B 9.35
ElectroCore (ECOR) United States $0.061B 0.00
Iterum Therapeutics (ITRM) Ireland $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
IntelGenx Technologies (IGXT) Canada $0.060B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 1.83
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Capnia (SLNO) United States $0.051B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
CTI BioPharma (CTIC) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Opexa Therapeutics (ACER) United States $0.030B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Bio-Path Holdings (BPTH) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.013B 0.00
Shineco (TYHT) China $0.012B 17.67
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00